Our current study, focused on LIN28B-PBK signaling, in conjunction with our previous discovery of a LIN28B-RAN-AURKA network, [12] highlights two kinases that are downstream LIN28B/let-7 targets in neuroblastoma. The gene discussed is RAN; the disease is neuroblastoma.